Histological Hyperspectral Breast Cancer Recurrence Database (HistologyHSI-BC Recurrence)
- Laura Quintana-Quintana
- Esther Sauras-Colón
- Alessio Fiorin
- Javier Santana-Nunez
- Samuel Ortega
- Noèlia Gallardo-Borràs
- Alba Fischer-Carles
- Tábata Sánchez-Alcántara
- Himar Fabelo
- Laia Adalid-Llansa
- Daniel Mata-Cano
- Ramon Bosch-Príncep
- Marylène Lejeune
- Gustavo M. Callico
- Carlos López-Pablo
2025-11-28
Metastasis occurs in nearly 1 out of 3 breast cancer (BC) patients and significantly reduces survival rates, particularly in cases of distant metastases. As most distant metastases develop after diagnosis (i.e., recurrence) and remain incurable, there is a critical need for prognostic biomarkers to assess recurrence risk. Multimodal data analysis has emerged as a promising approach to integrate diverse information, offering a more comprehensive perspective. This study introduces the Histology HSI-BC (hyperspectral imaging - breast cancer) Recurrence Database, the first publicly accessible multimodal database designed to advance BC distant recurrence prediction. The database comprises 47 histopathological whole-slide images, 677 hyperspectral (HS) images, and clinical and demographic data from 47 BC patients, of whom 22 (47%) experienced distant recurrence over a 12-year follow-up. Histopathological slides were digitized using a whole-slide scanner and annotated by expert pathologists, while HS images were acquired with an HS camera coupled to a bright-field microscope. This database provides a promising resource for studying BC recurrence prediction and personalized treatment strategies by integrating the aforementioned multimodal data.